BioWave Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Private

  • Employees
  • 72

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $25K

  • Investors
  • 2

BioWave General Information

Description

Developer of neuromodulation therapy medical devices designed to provide pain relief. The company's devices specialize in the treatment of chronic, acute, and postoperative musculoskeletal pains, enabling patients to alleviate pain through effective neurostimulation services.

Contact Information

Website
www.biowave.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 8 Knight Street
  • Suite 201
  • Norwalk, CT 06851
  • United States
+1 (877)
Primary Industry
Therapeutic Devices
Vertical(s)
Digital Health
Corporate Office
  • 8 Knight Street
  • Suite 201
  • Norwalk, CT 06851
  • United States
+1 (877)

BioWave Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioWave Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 05-Mar-2025 $25K Completed Generating Revenue
7. Later Stage VC 29-Jul-2022 Completed Generating Revenue
6. Debt - PPP 01-May-2020 Completed Generating Revenue
5. Later Stage VC (Series E) 20-Mar-2020 Completed Generating Revenue
4. Later Stage VC (Series D) 29-Jan-2016 Completed Generating Revenue
3. Later Stage VC 19-Sep-2007 Completed Generating Revenue
2. Later Stage VC (Series B) 27-Mar-2002 $821K $1.82M Completed Generating Revenue
1. Later Stage VC $1M $1M Completed Startup
To view BioWave’s complete valuation and funding history, request access »

BioWave Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series D
Series C
Series B 3,028,075 $0.010000 $0.54 $0.54 1x $0.54 6.69%
Series A 1,971,925 $0.010000 $0.54 $0.54 1x $0.54 4.36%
To view BioWave’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

BioWave Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of neuromodulation therapy medical devices designed to provide pain relief. The company's devices specialize i
Therapeutic Devices
Norwalk, CT
72 As of 2025

San Diego, CA
 

Austin, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioWave Competitors (13)

One of BioWave’s 13 competitors is Mainstay Medical, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mainstay Medical Venture Capital-Backed San Diego, CA
MicroTransponder Venture Capital-Backed Austin, TX
Nevro Formerly VC-backed Redwood City, CA
ARPwave Formerly VC-backed Apple Valley, MN
Spine Wave Venture Capital-Backed Shelton, CT
You’re viewing 5 of 13 competitors. Get the full list »

BioWave Patents

  • 42

    Total Documents Applications and Grants

  • Total Patents Families

  • 15

    Granted

  • 6

    Pending

  • Expiring in next 12 mo

BioWave Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240252819-A1 Systems and methods for optimizing use of a medical device for pain management Pending 26-Jan-2023
US-D877918-S1 Electrotherapy and neurostimulation medical device Active 23-Oct-2018
US-20210178158-A1 Wearable system for an electrotherapy device Active 23-Oct-2018
US-11633594-B2 Electrotherapy and neurostimulation medical device apparatus and method Active 23-Oct-2018
US-20200121925-A1 Electrotherapy and neurostimulation medical device apparatus and method Active 23-Oct-2018 A61N1/36021
To view BioWave’s complete patent history, request access »

BioWave Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioWave Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Connecticut Innovations Venture Capital Minority
NorthStar Pain Management Corporation Minority
To view BioWave’s complete investors history, request access »

Ready to get started?

Request a free trial

BioWave FAQs

  • When was BioWave founded?

    BioWave was founded in 2000.

  • Where is BioWave headquartered?

    BioWave is headquartered in Norwalk, CT.

  • What is the size of BioWave?

    BioWave has 72 total employees.

  • What industry is BioWave in?

    BioWave’s primary industry is Therapeutic Devices.

  • Is BioWave a private or public company?

    BioWave is a Private company.

  • What is BioWave’s current revenue?

    The current revenue for BioWave is .

  • How much funding has BioWave raised over time?

    BioWave has raised $7.53M.

  • Who are BioWave’s investors?

    Connecticut Innovations and NorthStar Pain Management have invested in BioWave.

  • Who are BioWave’s competitors?

    Mainstay Medical, MicroTransponder, Nevro, ARPwave, and Spine Wave are some of the 13 competitors of BioWave.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »